IDENTIFIKASI POTENTIALLY INAPPROPRIATE MEDICATIONS (PIMs) PADA PASIEN DIABETES MELLITUS GERIATRI BERDASARKAN KRITERIA BEERS 2023 DI RSUD CIAMIS PERIODE JANUARI – JUNI 2025

Solihah, Silfi Isyahul (2026) IDENTIFIKASI POTENTIALLY INAPPROPRIATE MEDICATIONS (PIMs) PADA PASIEN DIABETES MELLITUS GERIATRI BERDASARKAN KRITERIA BEERS 2023 DI RSUD CIAMIS PERIODE JANUARI – JUNI 2025. Sarjana thesis, Universitas Bakti Tunas Husada.

	Text (Cover dan Abstrak) Cover & Abstrak_Silfi Isyahul.pdf Download (196kB)
	Text (BAB I-V) BAB I-V_Silfi Isyahul.pdf Restricted to Repository staff only Download (380kB) | Request a copy
	Text (DAFTAR PUSTAKA) DAFTAR PUSTAKA_Silfi Isyahul Solihah.pdf Download (203kB)

Abstract

ABSTRAK Identifikasi Potentially Inappropriate Medications (PIMs) pada Pasien Diabetes Mellitus Geriatri Berdasarkan Kriteria Beers 2023 di RSUD Ciamis Periode Januari–Juni 2025 Silfi Isyahul Solihah S1 Farmasi, Universitas Bakti Tunas Husada Tasikmalaya Abstrak Pasien geriatri dengan diabetes mellitus berisiko mengalami Potentially Inappropriate Medications (PIMs) akibat penurunan fungsi fisiologis tubuh dan penggunaan banyak obat (polifarmasi). Penelitian ini bertujuan mengidentifikasi kejadian PIMs pada pasien geriatri dengan diabetes mellitus di RSUD Ciamis berdasarkan Kriteria Beers 2023. Penelitian menggunakan metode deskriptif retrospektif melalui data rekam medis periode Januari–Juni 2025. Hasil menunjukkan 35 dari 60 pasien (58,3%) mengalami PIMs dengan total 38 kejadian, dengan sulfonilurea sebagai golongan obat terbanyak. Disimpulkan bahwa kejadian PIMs masih relatif tinggi sehingga diperlukan evaluasi penggunaan obat secara berkala pada pasien geriatri. Kata kunci: Diabetes mellitus, Potentially Inappropriate Medications (PIMs), Kriteria Beers 2023 Abstract Geriatric patients with diabetes mellitus are at risk of experiencing Potentially Inappropriate Medications (PIMs) due to pharmacokinetic and pharmacodynamic changes as well as polypharmacy. This study aimed to identify the occurrence of PIMs in geriatric patients with diabetes mellitus at RSUD Ciamis based on the Beers Criteria 2023. This research employed a descriptive retrospective method using medical record data from January to June 2025. The results showed that 35 out of 60 patients (58.3%) experienced PIMs with a total of 38 cases, with sulfonylureas being the most commonly identified drug class. It was concluded that the incidence of PIMs remains relatively high; therefore, periodic medication review is necessary in geriatric patients. Keywords: Diabetes mellitus, Potentially Inappropriate Medications (PIMs), Beers Criteria 2023

Actions (login required)

View Item